Search

Displaying results 7471 - 7480 of 10000 in total
  1. Drug

    Azlocillin

    go.drugbank.com/drugs/DB01061
    Approved

    Azlocillin is a semisynthetic ampicillin-derived acylureido penicillin.

  2. Drug

    Natamycin

    go.drugbank.com/drugs/DB00826
    ApprovedInvestigational

    Amphoteric macrolide antifungal antibiotic from Streptomyces natalensis or S. chattanoogensis. It is used for a variety of fungal infections, mainly topically. [PubChem]

    International brands: N-Mycin
  3. Drug

    LGD-3303

    go.drugbank.com/drugs/DB13937
    Experimental

    An androgen receptor modulator.

  4. Drug

    Beclomethasone 17-monopropionate

    go.drugbank.com/drugs/DB14221
    Experimental

    An ester of beclomethasone.

  5. Drug

    LGD-2226

    go.drugbank.com/drugs/DB08089
    Experimental

    An androgen receptor modulator.

  6. Drug

    Oxelumab

    go.drugbank.com/drugs/DB16663
    Investigational

    Oxelumab is under investigation in clinical trial NCT00983658 (A Study of HuMAb OX40L in the Prevention of Allergen-induced Airway Obstruction in Adults With Mild Allergic Asthma).

  7. Drug

    Elzovantinib

    go.drugbank.com/drugs/DB18918
    Investigational

    Elzovantinib is under investigation in clinical trial NCT03993873 (Study of TPX-0022 in Patients With Advanced NSCLC, Gastric Cancer or Solid Tumors Harboring Genetic Alterations in MET).

  8. Drug

    Licogliflozin

    go.drugbank.com/drugs/DB15048
    Investigational

    Licogliflozin is under investigation in clinical trial NCT03320941 (A Dose-finding Study to Evaluate the Change in Weight After Treatment With LIK066 in Japanese Patients With Obesity).

  9. Drug

    Ganaplacide

    go.drugbank.com/drugs/DB16173
    Investigational

    Ganaplacide is under investigation in clinical trial NCT03167242 (Efficacy and Safety of KAF156 in Combination With LUM-SDF in Adults and Children With Uncomplicated Plasmodium Falciparum Malaria).

  10. Drug

    Pateclizumab

    go.drugbank.com/drugs/DB14997
    Investigational

    With Adalimumab in Combination With a DMARD in Patients With Active Rheumatoid Arthritis). … Pateclizumab is under investigation in clinical trial NCT01225393 (A Study to Evaluate the Efficacy and Safety of MLTA3698A in Combination With a Disease-Modifying Anti-Rheumatic Drug (DMARD) Compared